OCGN
Ocugen, Inc.NASDAQHealthcare$1.79+0.00%ClosedMarket Cap: $586.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-45.44
P/S
131.52
EV/EBITDA
-9.83
DCF Value
$-0.18
FCF Yield
-9.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-1425.7%
Net Margin
-1537.4%
ROE
-2626.4%
ROA
-153.2%
ROIC
-269.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $-193.0K | 100.0% | $-17.0M | $-17.7M | $-0.06 | — |
| FY 2025 | $4.4M | 45.9% | $-62.9M | $-67.8M | $-0.23 | — |
| Q3 2025 | $1.8M | 100.0% | $-17.6M | $-20.1M | $-0.07 | — |
| Q2 2025 | $1.4M | 100.0% | $-13.8M | $-14.7M | $-0.05 | — |
| Q1 2025 | $1.5M | 100.0% | $-14.5M | $-15.3M | $-0.05 | — |
| Q4 2024 | $764.0K | 100.0% | $-13.8M | $-13.9M | $-0.05 | — |
| FY 2024 | $4.1M | 51.5% | $-54.8M | $-54.1M | $-0.20 | — |
| Q3 2024 | $1.1M | 100.0% | $-13.3M | $-13.0M | $-0.05 | — |
| Q2 2024 | $1.1M | 100.0% | $-15.4M | $-15.3M | $-0.04 | — |
| Q1 2024 | $1.0M | 100.0% | $-12.2M | $-11.9M | $-0.05 | — |
| Q4 2023 | $6.0M | 100.0% | $-8.6M | $-9.5M | $-0.04 | — |
| FY 2023 | $6.0M | 88.3% | $-65.5M | $-63.1M | $-0.26 | — |